岱美股份(603730.SH):控股股東岱美投資及其一致行動人合計減持“岱美轉債”103.13萬張
格隆匯6月12日丨岱美股份(603730.SH)公佈,2024年6月12日,公司收到控股股東岱美投資及其一致行動人姜明先生、上海富善投資有限公司-富善投資安享尊享11號私募證券投資基金的通知,2024年6月4日至2024年6月12日期間,岱美投資、姜明先生、上海富善投資有限公司-富善投資安享尊享11號私募證券投資基金通過上海證券交易所交易系統以集中競價和大宗交易方式合計減持“岱美轉債”1,031,340張,佔發行總量的11.36%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.